# Role of PBAF and Mediator kinase module in the RELA-dependent activation of CXCL1–3 inflammation genes of the NF-kB pathway

**Authors:** Alexey V. Feoktistov, Anton A. Grigel, Ivan A. Zolin, Darya M. Yurkina, Anna V. Tvorogova, Asya M. Azieva, Sofia G. Georgieva, Nataliya V. Soshnikova

PMC · DOI: 10.3389/fimmu.2026.1702928 · Frontiers in Immunology · 2026-01-30

## TL;DR

This study shows how two protein complexes, PBAF and MKM, work together to activate genes involved in inflammation through distinct steps in gene transcription.

## Contribution

The study reveals non-redundant, sequential roles of PBAF and MKM in the transcriptional activation of NF-κB-dependent chemokine genes.

## Key findings

- PBAF is essential for promoter recruitment and stabilization of the transcription machinery.
- MKM facilitates the transition to productive elongation by increasing Pol II-S2P levels.
- PBAF and MKM physically interact and additively enhance transcription of CXCL1-3 genes.

## Abstract

The transcription of inflammatory genes is rapidly induced by extracellular stimuli through coordinated actions of transcription factors and large coactivator complexes. However, the mechanistic interplay between specific chromatin remodelers and kinase modules in driving the transcriptional burst of early inflammatory genes remains poorly understood. This study investigates the roles of the PBAF chromatin remodeling complex and the Mediator kinase module (MKM) in activating NF-κB-dependent CXCL1, CXCL2, and CXCL3 chemokine genes.

We employed a combination of molecular and genomic techniques. Protein-protein interactions were analyzed via co-immunoprecipitation (co-IP). Transcriptional outputs of CXCL1-3 genes were measured by quantitative mRNA analysis. Chromatin immunoprecipitation (ChIP) was used to assess the occupancy of RNA polymerase II (Pol II), its elongating form (Pol II-S2P), the MKM subunit CDK8, and the PBAF complex (via its BAF200 subunit) at target gene promoters. Functional contributions of the complexes were dissected using siRNA-mediated knockdown of BAF200 (PBAF) and small-molecule inhibition of the MKM.

PBAF and MKM physically interact with each other and with the NF-κB subunit RELA, and both complexes additively contribute to the transcriptional activation of CXCL1-3 genes. Knockdown of the PBAF-specific subunit BAF200 resulted in the loss of the entire PBAF complex from chromatin, a reduction in total Pol II and CDK8 promoter occupancy, and consequently, impaired gene induction. In contrast, MKM inhibition did not affect PBAF recruitment but specifically reduced the level of elongating Pol II-S2P and transcriptional activation. These data indicate non-redundant, stage-specific functions.

Our results demonstrate that the PBAF complex and the Mediator kinase module regulate distinct, sequential steps in the transcription cycle of CXCL1-3 genes. PBAF is critical for the initial promoter recruitment or stabilization of the transcription machinery, while MKM primarily facilitates the transition into productive elongation. Their additive positive effect and physical interaction suggest a coordinated mechanism where PBAF establishes a permissive chromatin context, enabling subsequent MKM-dependent phosphorylation events that drive the transcriptional burst of key inflammatory chemokines.

## Linked entities

- **Genes:** CXCL1 (C-X-C motif chemokine ligand 1) [NCBI Gene 2919], CXCL2 (C-X-C motif chemokine ligand 2) [NCBI Gene 2920], CXCL3 (C-X-C motif chemokine ligand 3) [NCBI Gene 2921], ARID2 (AT-rich interaction domain 2) [NCBI Gene 196528]
- **Proteins:** RELA (RELA proto-oncogene, NF-kB subunit), RNA polymerase II (DNA-directed RNA polymerase II subunit RPB7), Polr2A (RNA polymerase II subunit A), CDK8 (cyclin dependent kinase 8)

## Full-text entities

- **Genes:** CDK8 (cyclin dependent kinase 8) [NCBI Gene 1024] {aka IDDHBA, K35}, CXCL2 (C-X-C motif chemokine ligand 2) [NCBI Gene 2920] {aka CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, CXCL13 (C-X-C motif chemokine ligand 13) [NCBI Gene 10563] {aka ANGIE, ANGIE2, BCA-1, BCA1, BLC, BLR1L}, CXCL1 (C-X-C motif chemokine ligand 1) [NCBI Gene 2919] {aka FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3}, CXCL3 (C-X-C motif chemokine ligand 3) [NCBI Gene 2921] {aka CINC-2b, GRO3, GROg, MIP-2b, MIP2B, SCYB3}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ARID2 (AT-rich interaction domain 2) [NCBI Gene 196528] {aka BAF200, CSS6, SMARCF3, ZIPZAP, p200}
- **Diseases:** inflammation (MESH:D007249)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12901329/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12901329/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC12901329/full.md

---
Source: https://tomesphere.com/paper/PMC12901329